anonymous
Guest
anonymous
Guest
Dying. This town hall is funnier than I thought it would be.
Based on the drug profile clinically no reason why Ilumya is not $2b - but it will never be unless major changes in the US group including CEO and attitude of excellence vs the incompetence we currently have. Still sad, still leaving. Worst. Launch. In. History. Generic. Mindset. Is. About. Penny. Pinching. Shit. Quality. People. Products. Now. Ethics. (Lack). Out. In. Public. Time. To. Quit
nothing more to addYou know it’s bad when a multi billion dollar company can’t figure out how to use audio equipment. When you have people like Abhay and his crony Hagler and Trash Bag Steve, you know the company isn’t going anywhere. Time to Clean house and hit reset.
That revenue number for Ilumya was read wrong. He added a zero. It was meant to be $200 million annual, which will be a stretch number for Ilumya and this bunch of leadership cronies. They have screwed the pooch with their one shot at this and the drug is pigeon holed as well as barely impossible to get. If this drug makes $200 million in a year it will be time to kiss Bangladesh Bobby!!!